Clinical Trial

Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-02-28; most recent amendment 2025-11-20.
Status change: Not Yet Recruiting → Recruiting 2025-07-02
Trial Details
NCT Number NCT06295588
Lead Sponsor University of Rochester
Collaborators: National Cancer Institute (NCI)
Conditions Fatigue, Inflammation
Enrollment 40 participants
Start Date 2025-07-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-26